ConforMIS Raises $168 Million Series E Round
8/1/2013 7:36:02 AM
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
ConforMIS closes a $168 million funding round for its personalized implant technology. ConforMIS closed a Series E round worth $167.7 million, raised from a consortium of 88 unnamed investors, according to regulatory filings. The Bedford, Mass.-based medical device company makes personalized knee implants based on scans detailing patients' physiology, creating customized instruments and implants that are shipped in a sterile package surgeons can open on the operating table.
Help employers find you! Check out all the jobs and post your resume.
comments powered by